conducted the present pilot study [2] to examine the ratio of acylcarnitines to free carnitines (AC/FC), a biomarker of cardiomyocyte carnitine insufficiency and impaired -oxidation [3], either in symptomatic HF with reduced left ventricular ejection fraction (LVEF) HFrEF or HF with preserved LVEF (HFpEF), and demonstrated that AC/FC levels in admission were significantly higher than in asymptomatic staged HF, decreasing to comparable levels at discharge
For Nerve Damage or Neurological Support Though less common, BPC-157 may offer neuroprotective effects, especially in cases of peripheral nerve injury or neuroinflammation
This article was updated with additional information on pricing and discounts for Zepbound.
Source: Hwang, et al JAMA Health Forum March 14, 2025 Implications for employers: This modeled study suggests that employers should at least offer access to the two combination generic medications for obesity if budgets allow
The presence of competing products based on GLP-1 injection and other obesity treatment solutions could pose additional difficulties during product commercialization